Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 16/20 | 0.46 |
| ▸ | PDE4A | P27815 | 14/20 | 0.46 |
| ▸ | PDE4B | Q07343 | 14/20 | 0.46 |
| ▸ | PDE4C | Q08493 | 14/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 14/20 | 0.46 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4420069 | 0.80 | CHRM3 (0.70) | CHRM3PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL4423241 | 0.60 | CHRM3 (1.00) | CHRM3PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL4422714 | 0.60 | CHRM3 (1.00) | CHRM3PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL20302733 | 0.59 | HCRTR2 (0.41) | CHRM4 | |
| SCHEMBL11461060 | 0.58 | CA1 (0.36) | CHRM3KDM4EMEN1ALDH1A1GAA | |
| SCHEMBL11470571 | 0.58 | CA1 (0.36) | CHRM3KDM4EMEN1ALDH1A1GAA | |
| SCHEMBL24174872 | 0.58 | GLS (0.41) | — | |
| SCHEMBL4420662 | 0.58 | CHRM3 (1.00) | CHRM3PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL4431276 | 0.58 | CHRM3 (1.00) | CHRM3PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL973195 | 0.57 | HRH3 (0.41) | L3MBTL1KDM4EALDH1A1GAAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7544675-B2 | Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions | UCB, S.A. (BE) | 2009-06-09 | — | — | US | disclosed |
| US-20060074068-A1 | Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions | UCB, S.A. (BE) | 2006-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060074068-A1 | Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions | PDE7A, CHRM3, PDE4B | CHRM3 2/4885PDE4A 5/4885PDE4B 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.